The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ABBVIE INC COM 00287Y109 4,427 50,000 SH   SOLE   50,000 0 0
ADAMAS PHARMACEUTICALS INC COM 00548A106 758 200,000 SH Call SOLE   200,000 0 0
AMERISOURCEBERGEN CORP COM 03073E105 1,700 20,000 SH   SOLE   20,000 0 0
ANTARES PHARMA INC COM 036642106 1,410 300,000 SH   SOLE   300,000 0 0
CARDINAL HEALTH INC COM 14149Y108 1,770 35,000 SH   SOLE   35,000 0 0
CLOVIS ONCOLOGY INC COM 189464100 1,564 150,000 SH   SOLE   150,000 0 0
CLOVIS ONCOLOGY INC COM 189464100 1,043 100,000 SH Call SOLE   100,000 0 0
CVS HEALTH CORP COM 126650100 3,715 50,000 SH   SOLE   50,000 0 0
FOAMIX PHARMACEUTICALS LTD SHS M46135105 167 50,000 SH Call SOLE   50,000 0 0
FOAMIX PHARMACEUTICALS LTD SHS M46135105 1,166 350,000 SH   SOLE   350,000 0 0
GILEAD SCIENCES INC COM 375558103 4,549 70,000 SH   SOLE   70,000 0 0
GLAXOSMITHKLINE PLC SPONSORED ADR 37733W105 4,699 100,000 SH   SOLE   100,000 0 0
GREENLANE HLDGS INC CL A 395330103 570 175,000 SH   SOLE   175,000 0 0
MCKESSON CORP COM 58155Q103 1,383 10,000 SH   SOLE   10,000 0 0
TYME TECHNOLOGIES INC COM 90238J103 3,045 2,175,000 SH   SOLE   2,175,000 0 0
VIKING THERAPEUTICS INC COM 92686J106 2,005 250,000 SH   SOLE   250,000 0 0